Due to high frequency of side effects caused by high dose total body irradiation (TBI) the non-myeloablative regimen together with cytotoxic agents is currently used especially for elderly patients. However, immediate and long-term effects of low dose irradiation employed in allogeneic transplantation on stem cells is less well known. We have studied the effect of low dose 3 Gy TBI on the number of hematopoietic stem cell (HSC) clones contributing simultaneously to granulocyte production in rhesus macaque. The number of clones post-3 Gy TBI decreased markedly by 2-3 weeks post-3 Gy TBI, followed by a period of clonal instability, and recovery to almost pre-3 Gy TBI clonal diversity. The clones accounting for this recovery contributed pre-3 Gy TBI, suggesting the profound initial impact of TBI was on a pool of progenitor cells, where as most of the more primitive HSCs remained unaffected and were able to regain contributing to hematopoiesis after recovery. Clonal fluctuation may indirectly suggest the presence of short term/long term HSC populations in rhesus macaque bone marrow as reported in a mouse model. The results indicate that even low dose irradiation affects hematopoietic clonal dynamics, and have implications for design of conditioning regimens for transplantation purposes.
Introduction
TBI is used therapeutically in the treatment of hematopoietic malignancies and to condition recipients for hematopoietic stem cell transplantation, in order to decrease competition from endogenous HSCs, suppress the immune system in order to prevent graft rejection, and eradicate residual tumor cells 1 . TBI doses of 10 Gy or more are used to ablate residual hematopoiesis in patients that require autologous or allogeneic stem cell transplantation in order to recover hematopoiesis. Doses in the range of 1-5 Gy are much less well studied, but are beginning to be utilized in a wide variety of clinical applications, most notably in nonablative allogeneic stem cell transplantation 2 . Since the side effects of irradiation in these dose ranges are much milder than following high-dose TBI, this approach has been utilized to extend allografting to older patients or those with serious organ dysfunction 3 . However, further optimization and prediction of toxicity for this and other applications would be greatly aided by an understanding of the impact of TBI on stem cell dynamics in vivo.
We have developed an approach that allows direct tracking of individual stem and progenitor cell clones in a large animal rhesus macaque model with direct relevance to human stem cell biology and transplantation 4 . Animals are transplanted with autologous primitive CD34+ hematopoietic cells transduced with standard helper-free retroviral vectors containing marker DNA sequences. After engraftment, animals can be followed long-term for the presence of vector-containing progeny of primitive progenitor and stem cells. Since each vector insertion is stable and semi-random in the genome, a sensitive
and specific linear amplification-mediated PCR (LAM-PCR) technique can be used to
For personal use only. on . by guest www.bloodjournal.org From identify and track specific vector-genomic DNA junctions 5 . Each individual junction is a unique tag for a stem or progenitor cell and all its progeny. We have previously reported that hematopoiesis is highly polyclonal and stably-derived from many multi-lineage clones post-transplantation in rhesus macaques 6 . We have utilized this approach to directly investigate the impact of irradiation on in vivo hematopoietic dynamics. The results suggests that TBI, even at relatively low doses not resulting in significant hematopoietic suppression, profoundly but temporarily impacts on the number of stem and progenitor cell clones contributing to mature peripheral blood cell production. These findings have important implications for design of conditioning regimens prior to transplantation and also offer insights into the in vivo behavior of stem cells. Stem cell factor/granulocyte-stimulating factor mobilized peripheral blood CD34+ cells were collected from 2 animals (96E019 and 96E025) by aphaeresis, transduced with the retroviral vectors G1Na and/or LNL6, containing the neomycin phosphotransferase gene, and re-infused following 10 Gy of TBI [7] [8] [9] . While transduction conditions were the same in both animals, CD34+ enrichment and total CFUs were 31% and 35% lower in animal 96E025 as compared to animal 96E019. Details of the vectors, transduction procedures, and gene transfer efficiency in the first year following transplantation have been previously published for both animals 10 . In the current study, 3 Gy of total body gamma irradiation was delivered by a cesium source at a rate of 8.8 cGy/minute. No stem cell rescue or transfusion support was given following this dose of TBI. Blood samples were collected periodically for blood cell counts. Granulocytes and mononcuclear cells were separated via centrifugation over Lymphocyte Separation Medium (Organon Teknika, Durham, NC), with purities of >95%. DNA isolation of each cell fraction was carried out using the QIAamp DNA blood Midi kit (Qiagen, Valencia, CA, USA).
Linear amplification mediated PCR (LAM-PCR:
The number of retrovirally-marked progenitor or stem cell clones contributing to granulocyte production was determined Cloning and sequencing: LAM-PCR amplified fragments were isolated from Spreadex EL 1200 gels using the BandPick TM device (Elchrom Scientific AG, Cham, Switzerland).
The isolated fragments were amplified for 30 cycles using a primer pair 5'-CCTTGCAAAATGGCGTTACT-3' and 5'-AGTGGCACAGCAGTTAGG-3'. The amplification conditions were the same as in LAM-PCR nested amplification. The isolated fragment was cloned into TOPO pCR4 vector (Invitrogen, Carlsbad, CA, USA)
for sequencing.
Tracking of individual clones:
The individual retrovirus integration clones identified by sequencing were tracked using specific PCR primers for the 5'LTR and flanking genomic For personal use only. on September 14, 2017. by guest www.bloodjournal.org From
Marking level analysis:
The retrovirus marking level (relative ratio of retrovirus genome containing cells versus total cells, assuming 1 insertion per transduced cell) was measured as previously described using PCR amplifying retroviral neomycin phosphotransferase and cellular ß-actin sequences in DNA isolated from peripheral blood granulocytes at different time points pre-and post-TBI 12 . Nested PCR was run using 100ng DNA as template. Band intensity after auto radiography was determined by
PhosphoImager (Molecular Dynamics, Sunnyvale, CA, USA) and copy number was calculated by linear regression analysis in comparison to a set of known copy number controls amplified simultaneously.
Statistical analysis:
The statistical analysis was done using paired t tests for clone numbers between different time points in each animal.
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Results
The rhesus macaque model has proven predictive of human stem cell behavior and transduction capabilities with potential impact on understanding human hematopoiesis 4 .
For the current study, we chose 2 animals that had been previously transplanted with retrovirally-transduced CD34+ cells (Fig. 1) . Standard amphotropic retroviral vectors were utilized for the transduction, carrying a neomycin phosphotransferase expected to have no impact on stem or progenitor cell behavior 13 . We studied clonal contributions in granulocytes, which have a brief life span of less than 3-4 days in the blood and rapid maturation from primitive precursor cells, in both animals, since they best reflect ongoing hematopoiesis from stem or progenitor cells. We also studied clonal contributions in lymphocytes, which may have life spans of months to years, in one animal following 3
Gy TBI. We chose a dose of 3 Gy TBI, since this dose is within the range utilized in non-ablative allogeneic transplantation protocols [14] [15] [16] . Since the animals had been previously transplanted, we utilized a dose lower than naïve animals had tolerated with moderate count suppression in our previous studies 17 .
The blood cell counts showed a pattern of moderate and transient suppression following a single dose of 3 Gy TBI (Fig. 2 ). There was no significant impact on red blood cell 
levels of 0.5-10% 11 . Thus for each sample, 3 independent amplifications of 6
replicates were performed to determine contributing clone numbers.
As expected based on our previous reports, both animals had polyclonal and stable clonal contributions to granulocyte and lymphocyte production at time points preceding the TBI treatment. In animal 96E019, there was a rapid and significant (p<0.05) decrease in the number of independent clones contributing to granulocyte production within 1-3 weeks of 3 Gy TBI. This decrease was followed by a 6 month period of marked clonal fluctuation, finally succeeded by a stable recovery (p<0.01) with contributing clone numbers approaching the pre-3 Gy TBI levels (Fig. 3A) . In the second animal, 96E025, a similar decline (p<0.001) in contributing clones was seen following 3 Gy TBI, with a more extended period of clonal disequilibrium. At least partial recovery close to baseline polyclonality was finally observed at 1 year 2 months post-3 Gy TBI (Fig. 3B) . The clonal contributions to lymphocyte production were studied in animal 96E025. Before TBI, the mononuclear cell fraction, consisting of 90% T lymphocytes, showed similar clonal diversity as did granulocytes pre-TBI. There was no significant change in clone numbers contributing to lymphocytes pre-and post-3 Gy TBI (Fig. 3C ).
GeneScan analysis and confirmation with tracking primers indicated that recovery of clone numbers post-3 Gy TBI did not generally represent activation of previously completely quiescent or undetectable stem cell clones, but instead represented recovery of contribution from clones also detected pre-3 Gy TBI (Fig. 4A) . The clonal responses to
Gy TBI was confirmed by individual tracking of four individual independent retroviral
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Clones having integrations at 3q26.2, 18q21.2, 1p36.13, and 18q21.31 were amplified from different time points and showed persistent presence and variable detection correlating with findings on LAM-PCR and GeneScan analysis. Semi quantitative analysis of the clones integrated at 3q26.2 and 1p36.13 indicates that the relative contributions from these clones were relatively constant after recovery from TBI (Fig.   4C ).
The level of vector containing cells was stable in both animals pre-and post-3 Gy TBI treatment. Two years after the initial transplantation the retroviral marking level was 4-10% of circulating cells in 96E019, and remained at the same overall level post-3 Gy TBI despite clonal fluctuation and overall fewer clones contributing immediately following 3 Gy TBI. The marking level in the second monkey was lower, 1.5-3.0%, and remained at this level post-3 Gy TBI (Fig. 5 ). This suggests that the transduced clones were not inherently more susceptible to radiation effects. In our rhesus macaque model, we have the unique ability to identify and then follow the behavior of individual repopulating units over time, based on retroviral insertion sites serving as clonal tags for each transduced cell and its progeny 6 . We have investigated the impact of 3 Gy TBI on hematopoiesis. This dose range was chosen based on evidence cycle and contribute to hematopoiesis 24 . Even though some of the clones may have disappeared at the time of low dose TBI, there is no evidence for complete deletion of significant numbers of primitive long-term repopulating clones. However, we can not rule out a permanent impact of low-dose irradiation on the self-renewal or stressresponsiveness of these primitive cells. In a murine study, doses of as low as 1.6 Gy TBI produced profound defects in competitive repopulation ability, suggesting that even if
HSCs survive, they may have defects in homing or expansion upon reaching the marrow 25 .
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The prolonged time period before recovery of a more normal clonal pattern, even with this relatively low dose of irradiation, helps to explain the significant boost in engraftment seen after transplantation of donor cells following even very low dose TBI (0.5-1.6 Gy) compared to no radiation in the murine syngeneic transplantation model 20;26 .
In this setting we would hypothesize that normal non-irradiated HSCs home to the marrow and begin to cycle, proliferate and self-renew in response to open marrow niches, and out-compete the remaining damaged and irradiated recipient HSCs.
In conclusion, our current results indicate that low dose 3 Gy TBI can profoundly impact on hematopoietic activity in vivo without depleting hematopoietic stem cells, and thus should continue to be pursued, along with agents such as busulfan as effective and safe conditioning prior to transplantation. 
